PETRiS: PET-CT Registry of Perioperative Specimen evaluation
Research type
Research Study
Full title
A multicentric, observational, post-marketing, registry study to assess the correlation of high-resolution specimen PET-CT imaging, using the XEOS AURA 10 PET-CT, with the histopathology results and long-term outcome of patients undergoing resective cancer surgery.
IRAS ID
359599
Contact name
Vincent Keereman
Contact email
Sponsor organisation
XEOS Medical
Clinicaltrials.gov Identifier
Duration of Study in the UK
2 years, 5 months, 28 days
Research summary
This study is a registry study organized by XEOS Medical NV (“XEOS”). The study is purely observational, meaning that no invasive procedures are planned and that this study collects data that have already been or will be generated outside the context of this study.
Participating patients have planned or already undergone resective surgery in which a high-resolution PET-CT scan with the AURA 10 Specimen PET-CT Imager is planned or has been performed on the excised tissue.
In total, the estimated number of patients is about 850, including about 250 breast-conserving surgery patients, about 200 radical prostatectomy patients, about 200 spinocellular carcinoma of the head and neck area patients and about 200 patients with other indications.
Centers and countries that have the high-resolution PET-CT scanner can participate in this study. Countries participating in the study are mainly in Europe, including Switzerland and the United Kingdom, but may also include the United States and possibly other regions, depending on where the high-resolution PET-CT scanner will be available.
The purpose of this study is to generate valuable insights into the effectiveness and impact of PET-CT specimen scans in a real clinical setting, leading to improved evaluation of specimen scans and improved patient outcomes.
The study will collect data over a 3-year period, including follow-up to monitor clinical outcomes.
REC name
South West - Frenchay Research Ethics Committee
REC reference
25/SW/0143
Date of REC Opinion
12 Jan 2026
REC opinion
Further Information Favourable Opinion